Blum D, LaBarge S. Registered report: Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion.
eLife 2014;
3. [PMID:
25490933 PMCID:
PMC4270138 DOI:
10.7554/elife.04034]
[Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2014] [Accepted: 11/17/2014] [Indexed: 01/16/2023] Open
Abstract
The Reproducibility Project: Cancer
Biology seeks to address growing concerns about reproducibility in
scientific research by conducting replications of 50 papers in the field of cancer
biology published between 2010 and 2012. This Registered Report describes the
proposed replication plan of key experiments from ‘Tumour micro-environment
elicits innate resistance to RAF inhibitors through HGF secretion’ by
Straussman and colleagues, published in Nature in 2012 (Straussman et al., 2012). The key experiments being replicated
in this study are from Figure 2A, C, and D (and Supplemental Figure 11) and Figure 4C
(and Supplemental Figure 19) (Straussman et al.,
2012). Figure 2 demonstrates resistance to drug sensitivity conferred by
co-culture with some stromal cell lines and identifies the secreted factor
responsible as HGF. In Figure 4, Straussman and colleagues show that blocking the HGF
receptor MET abrogates HGF’s rescue of drug sensitivity. The Reproducibility
Project: Cancer Biology is a collaboration between the Center for Open Science
and Science Exchange, and the
results of the replications will be published by eLife.
DOI:http://dx.doi.org/10.7554/eLife.04034.001
Collapse